Oral semaglutide is soon to come to the market and will be useful for people with type 2 diabetes who are averse to injections and are needle phobic
On the heels of As of Monday January 5, 2026, patients will have access to the starter dose of the oral GLP-1, 1.5 mg, with additional strengths reported to be released by the end of the week
Gastrointestinal adverse events induced by metformin are associated with dose escalation, immediate-release formulations, alterations in gut microbiota, epigenetic susceptibility, inhibition of organic cation transporters, as well as interactions with serotonin, histamine, and enterohepatic circulation [72]
Try to focus on foods rich in nutrients, limit sugary and high-fat foods, and listen to your bodys signals of fullness to make more nutritious dietary choices.